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Cleft lipDevelopmental abnormalities of craniofacial structures and teeth often occur sporadically and the underlying
genetic defects are notwell understood, in part due to unknown gene–gene interactions. Pax9 andMsx1 are co-
expressed during craniofacial development, and mice that are single homozygous mutant for either gene
exhibit cleft palate and an early arrest of tooth formation. Whereas in vitro assays have demonstrated that
protein–protein interactions between Pax9 and Msx1 can occur, it is unclear if Pax9 and Msx1 interact
genetically in vivo during development. To address this question, we compounded the Pax9 and Msx1
mutations and observed that double homozygous mutants exhibit an incompletely penetrant cleft lip
phenotype. Moreover, in double heterozygous mutants, the lower incisors were consistently missing and we
ﬁnd that transgenic BMP4 expression partly rescues this phenotype. Reduced expression of Shh and Bmp2
indicates that a smaller “incisor ﬁeld” forms in Pax9+/−;Msx1+/− mutants, and dental epithelial growth is
substantially reduced after the bud to cap stage transition. This defect is preceded by drastically reduced
mesenchymal expression of Fgf3 and Fgf10, two genes that encode known stimulators of epithelial growth
during odontogenesis. Consistent with this result, cell proliferation is reduced in both the dental epithelium
and mesenchyme of double heterozygous mutants. Furthermore, the developing incisors lack mesenchymal
Notch1 expression at the bud stage and exhibit abnormal ameloblast differentiation on both labial and lingual
surfaces. Thus, Msx1 and Pax9 interact synergistically throughout lower incisor development and affect
multiple signaling pathways that inﬂuence incisor size and symmetry. The data also suggest that a combined
reduction of PAX9 andMSX1 gene dosage in humansmay increase the risk for orofacial clefting and oligodontia.ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The early development of mammalian craniofacial structures such
as jaws, secondary palate and teeth is controlled by reciprocal
interactions between ectodermal epithelium and neural crest-derived
mesenchyme. These interactions are tightly controlled and involve
dynamic changes in expression patterns of signaling molecules,
growth factors and their receptors, and transcription factors
(reviewed in Chai and Maxson, 2006). The developing mouse tooth
is a widely used system to investigate the functions of individual
genes in this process and has been highly informative to deﬁne the
molecular networks that control different steps during tooth
morphogenesis (Pispa and Thesleff, 2003; Tucker and Sharpe, 2004).
Several homologous genes are expressed in overlapping patterns
during tooth morphogenesis and their simultaneous inactivationoften results in a more severe phenotype when compared to that of
the single gene knockout mice. For example, consistent with
functional redundancy among closely related transcription factors,
double mutants lacking eitherMsx1 andMsx2, Dlx1 and Dlx2, Lhx6 and
Lhx7, or Gli2 and Gli3 exhibit phenotypes that occur earlier or that are
enhanced in severity relative to those in the respective single mutants
(Bei and Maas, 1998; Thomas et al., 1997; Denaxa et al., 2009;
Hardcastle et al., 1998). In contrast, it is unknown to what extent
genes encoding transcription factors that belong to different classes
and that recognize different DNA sequences functionally interact
during craniofacial and tooth development.
Pax9 and Msx1 encode transcription factors with different DNA
binding motifs, a paired domain and a homeodomain, respectively,
and are co-expressed during mouse craniofacial and tooth develop-
ment (Mackenzie et al., 1991; Neubuser et al., 1995). Targeted gene
inactivation of each gene in mice has shown that both genes are
essential for tooth and secondary palate development (Satokata and
Maas, 1994; Peters et al., 1998). In homozygous Pax9 orMsx1mutants,
all teeth fail to form and morphogenesis of the ﬁrst molar, which has
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formed a bud. At this stage, both genes are necessary to maintain the
mesenchymal expression of Bmp4 (Chen et al., 1996; Peters et al.,
1998), which is required for progression of the molar rudiment from
the bud stage to the cap stage (Jernvall et al., 1998; Bei et al., 2000). In
addition, heterozygous mutations in human MSX1 or PAX9 underlie
dominantly inherited oligodontia (congenital absence of at least six
permanent teeth, excluding third molars), and are infrequent-
ly associated with missing primary teeth and orofacial clefting
(Vastardis et al., 1996; Stockton et al., 2000; for recent reviews see
Vieira, 2008; Nieminen, 2009). In contrast to humans, heterozygous
Pax9 or Msx1 loss-of-function mutations in mice do not affect
secondary palate and tooth development, indicating that different
gene dosages are required in the two species. In support of this, a
reduction of functional Pax9 gene dosage to levels below heterozy-
gosity is associated with oligodontia as the predominant phenotype in
a Pax9 hypomorphic mouse model (Kist et al., 2005).
In this study, we provide genetic evidence for a critical interaction
between Pax9 and Msx1 in craniofacial and lower incisor develop-
ment. Whereas cleft lip formation is incompletely penetrant in Pax9−/−;
Msx1−/− double homozygous mutants, lower incisors are consistently
missing in Pax9+/−;Msx1+/− double heterozygous mice. Our data
demonstrate that the concomitant reduction of Pax9 and Msx1 gene
dosages affect lower incisor development during initiation, morphogen-
esis and differentiation, and these processes are sensitive to Bmp4 gene
dosage.Moreover, the regulationof Fgf3 and Fgf10expression in thedental
papilla of lower incisors is one critical downstream function of combined
Pax9 andMsx1 function that controls the normal growth of these teeth.
Materials and methods
Mouse mutants and phenotype analysis
Generation and genotyping of Pax9 and Msx1 knockout mice have
been described previously (Peters et al., 1998; Satokata and Maas,Fig. 1. Cleft lip in Pax9;Msx1 double homozygous mutant mice. (A) Head of a normal, newbo
andhypoplasia of themandible (arrow). (C) In newborn controlmice, a singlemidline furrow
mutant, leaving the left medial nasal process exposed. (E) Bilateral cleft lip (arrowheads), re
process; no, nostrils; ul, upper lip.1994). Three different genetic backgrounds were used in this study.
First, for scoring of cleft lip and skull abnormalities, transgenic rescue
experiments and whole-mount in situ hybridization, we crossed
BMP4 transgenic mice (Zhang et al., 2000), which were on a mixed
C57BL/6J;CBA/J genetic background, to Pax9/Msx1 double heterozy-
gous mice to generate triple mutants with a mixed C57BL/6J;CBA/J;
CD1 genetic background. Second, for histological analysis and gene
expression studies on sections, Pax9/Msx1 double heterozygous mice
on a CD1 background (NN10) or on a mixed C57BL/6;FVB;BALB/c
background were used. In both genetic backgrounds the phenotype of
missing incisors was fully penetrant. Mice on a mixed C57BL/6;FVB;
BALB/c background were also used for BrdU incorporation and
apoptosis assays. Staging of embryos was done by taking the morning
of vaginal plug detection as embryonic day 0.5 (E0.5). A careful
staging of embryos between E12.0 and E12.5 used for whole-mount
RNA in situ hybridization was carried out by comparing the number of
Shh-positive mystacial vibrissae rudiments, which develop in a highly
coordinated caudo-rostral pattern between E12.0 and E13.5 (Van
Exan and Hardy, 1984). Heterozygous and homozygous mutants
carrying the BMP4 transgene, whichwas previously shown to partially
rescue early molar development of Msx1 homozygous mutant em-
bryos (Zhao et al., 2000) were distinguished by DNA dot-blot analysis
as previously described (Zhang et al., 2000). Skeletal elements were
stained using Alcian Blue for cartilage and Alizarin Red for bone
(Peters et al., 1998). For histological analysis, tissues were ﬁxed with
4% paraformaldehyde, followed by standard parafﬁn embedding,
sectioning, and hematoxylin and eosin staining.
RNA in situ hybridization and Pax9 immunostaining
RNA in situ hybridization on whole-mounts was performed as
previously described (Sporle and Schughart, 1998). Non-radioactive,
mouse antisense RNA probes were generated using 640 bp Shh,
240 bp Bmp2, 1550 bp Bmp4, 1300 bp Fgf3, 580 bp Fgf10 and 625 bp
p21 fragments (Nakatomi et al., 2006; details available upon request),rn mouse. (B) Pax9−/−;Msx1−/− newborn mice exhibit reduced head size, low-set ears,
(arrowhead) divides the upper lip. (D)Unilateral cleft lip (arrow) of a Pax9−/−;Msx1−/−
sulting in medial nasal processes forming a ‘ﬂoating’ primary palate. mnp, medial nasal
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according to themanufacturer's protocol (Roche, IN, USA). In addition,
mRNA riboprobes for mouse Ameloblastin, Follistatin, Lef1, Msx1,
Notch1, Pax9, p21, Runx2,Wnt-5a, and rat Shh for in situ hybridization
on sections only were used as described (Aberg et al., 2004; Wang et
al., 2009). Detection of Pax9 protein on parafﬁn sections using a rat
monoclonal anti-Pax9 antibody and Fast Red as a color substrate was
performed as described previously (Gerber et al., 2002).
Cell proliferation assay and TUNEL staining
Timed pregnant mice were injected intraperitoneally with 1 ml/
100 g body weight of BrdU solution according to the manufacturer's
protocol (Invitrogen, CA, USA). After 2 h, mouse heads were dissected
and ﬁxed in 4% PFA/PBS, processed for parafﬁn sections (7 µm), and
BrdU incorporated cells were detected using a BrdU detection kit
(Invitrogen, CA, USA). Images of every second section from the center
of incisor teeth to the periphery were photographed, and ﬁve sections
were counted for each tooth from three different mice of each
genotype. A BrdU indexwas calculated by counting BrdU incorporated
cells divided by total cells (ascertained as hematoxylin-stainednuclei).Fig. 2. Skeletal defects of maxilla and lower jaw in newborn Pax9 and Msx1 single and Pa
compound mutants that involve homozygosity for Pax9 orMsx1 or both. The palatal process
absence of the upper incisors, single and compoundmutants exhibit a narrow and short prem
process of the premaxilla is Pax9-dependent (asterisks) and is not affected byMsx1-deﬁcienc
deﬁcient mice (open arrowheads). (D–F; J–L) Alveolar bones of the mandible are missing
mutants only (arrows). (E, F; J–L) The ventral, curved aspect of the lower jaw is ﬂattened (n
angular process; con, condylar process; cor, coronoid process; np, nasal process; ns, nasal sep
vo, vomer. Scale bars: 1 mm (A–C, G–I); 2 mm (D–F, J–L).The signiﬁcance between wild type and Pax9+/−;Msx1+/− mutant
incisors was evaluated by Student's t-test. Apoptotic cells were
identiﬁed on parafﬁn sections using TUNEL staining with the In Situ
Cell Death Detection Kit (Roche, IN, USA).
Results
Pax9 and Msx1 interact synergistically during upper lip development
The overlapping craniofacial expression patterns ofMsx1 and Pax9,
the ability of their gene products to interact in vitro, and the simi-
larities of dental abnormalities in humans and mice caused by
mutations in MSX1 (Msx1) and PAX9 (Pax9) suggested that these
genesmight interact in vivo. To test this hypothesis, we ﬁrst generated
Pax9+/−;Msx1+/−mice. Apart from dental abnormalities (see below),
these mice appeared healthy and were intercrossed to generate
mutants with a complete loss of Pax9 and Msx1. Newborn Pax9−/−;
Msx1−/− mice could be readily identiﬁed by midfacial hypoplasia
(Figs. 1A and B) and 39% (7/18) of these mutants exhibited unilateral
or bilateral cleft lip (Figs. 1C, D, and E), a defect that did not occur in
Pax9 or Msx1 single homozygous mutants (NN150 for each mutantx9;Msx1 compound mutant mice. (A–C; G–I) A cleft secondary palate is present in all
of the maxilla is displaced, which exposes the vomer and the nasal septum. Due to the
axilla (normal shape is outlined by dashed line). (B, C, I) The development of the palatal
y (G, H). (G–I) Conversely, the bony element of the nasal process is absent only inMsx1-
in all compound mutants shown. (E, F, L) The coronoid process is absent in Pax9−/−
ormal shape outlined by the dotted line) in compound mutants. ab, alveolar bone; ang,
tum; pmx, palatal process of maxilla; ppx, palatal process of premaxilla; px, premaxilla;
441M. Nakatomi et al. / Developmental Biology 340 (2010) 438–449line; data not shown). Thus, combined Pax9 and Msx1 nullizygosity
leads to a cleft lip phenotype that results from a genetic interaction
between these loci.
Whereas this result identiﬁed an important interaction between
Pax9 and Msx1 in upper lip development, skeletal staining of single
and relevant compound mutant mice showed that abnormalities in
the skull and jaws represent a combination of the defects seen in the
singlemutants. In addition to a cleft secondary palate (Figs. 2B, C, G, H,
and I), the predominant phenotype caused by absence of Pax9 alone is
an absence of the palatal processes in the posterior part of the
premaxilla (Figs. 2B, C, and I), whereas an anterior shortening of the
premaxilla due to a missing nasal process results from absence of
Msx1 (Figs. 2 G–I). In addition, due to the absence of teeth in all
mutants, the alveolar bones are missing in all mutants. In the lower
jaw, absence of the coronoid process is caused by absence of Pax9
(Figs. 2E, F, and L), whereas a ventral ﬂattening of the mandible
mainly results from Msx1 deﬁciency (Figs. 2J, K, and L).
The cleft lip phenotype observed in Pax9−/−;Msx1−/− mice was
incompletely penetrant in themixedC57BL/6J;CBA/J;CD1 genetic back-
ground, and successive breeding onto a CD1background suppressed the
expression of this defect. Thus, to gain insight into the molecular
pathways regulated by the genetic interaction between Pax9 andMsx1,
we carriedout a detailed analysis of the Pax9+/−;Msx1+/− lower incisor
phenotype, which was consistently manifested as a severe growth
defect in mixed C57BL/6J;CBA/J;CD1, mixed C57BL/6;FVB;BALB/c, and
in pure CD1 genetic backgrounds.Fig. 3. Oligodontia in Pax9/Msx1 double heterozygous mutant mice and in vivo rescue of
molars. Missing upper (B) and lower (E) third molars in adult Pax9+/−;Msx1+/− mutan
adult lower incisors. Upper incisors are present in all genotypes but are not shown. (H) Mi
in Pax9+/−;Msx1+/−;BMP4tg/tg mice. (J) Normal arrangement of dental tissues in the low
Pax9+/−;Msx1+/− mutants and a tissue resembling bone marrow was observed instea
ameloblasts and enamel are missing. The dentin is connected to bone by a periodontal li
bone; am, ameloblasts; de, dentin; en, enamel; od, odontoblasts; pl, periodontal ligamenPax9+/−;Msx1+/− mutant mice exhibit oligodontia, which can be
partially rescued by transgenic expression of BMP4
Whereas the dentition is normal in single heterozygous Pax9+/− or
Msx1+/−mutantmice, all adult Pax9+/−;Msx1+/−mutants (nN45 for
each genetic background) lack lower incisors (Fig. 3H), and with
incomplete penetrance in the C57BL/6J;CBA/J;CD1 genetic back-
ground, upper (8/14; 57%) and lower (6/14; 43%) third molars
(Figs. 3B and E). Histological analysis revealed that no remnants of
lower incisor tissue were detectable in adult Pax9+/−;Msx1+/−
mutant mice (Fig. 3K). Obvious developmental abnormalities other
than oligodontia were not observed in Pax9+/−;Msx1+/− mutants.
Since Msx1 and Pax9 are each required for the expression of Bmp4 in
dental mesenchyme during early tooth formation (Chen et al., 1996;
Peters et al., 1998), we examined if the formation of affected teeth
could be rescued by transgenic expression of Bmp4. This transgene, a
human BMP4 cDNA, is expressed in the dental mesenchyme and
analysis of adult Pax9+/−;Msx1+/−;BMP4tg/tg mutants on a C57BL/6J;
CBA/J;CD1 genetic background showed that upper as well as lower
third molars were present in all (n=8) of these mice (Figs. 3C and F).
Lower incisors were found in the majority (42/48, 87.5%) of animals
but were hypoplastic (Fig. 3I). At a lower frequency (32/74; 43%),
erupted lower incisors were found in Pax9+/−;Msx1+/−mutants that
carried only one transgenic BMP4 allele. In contrast, erupted lower
incisors were not observed in Pax9+/−;Msx1+/−;BMP4+/tg or Pax9+/−;
Msx1+/−;BMP4tg/tg mice when these mutations were kept on a puretooth formation by transgenic BMP4. (A, D) Normal adult upper (A) and lower (D)
t mice. (C, F) Rescued third molars in Pax9+/−;Msx1+/−;BMP4tg/tg mice. (G) Normal
ssing lower incisors in Pax9+/−;Msx1+/− mice and (I) partially rescued lower incisors
er incisor. (K) No remnants of dental tissues are detectable in the lower jaw of adult
d. (L) In rescued lower incisors, the thickness of the dentin layer is reduced, and
gament, which is normally present only on the enamel-free lingual side. ab, alveolar
t; pm, periodontal mesenchyme.
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suppressed in this genetic background. Consistent with a signiﬁcant
inﬂuence of the genetic background on lower incisor development,
we observed that Msx1+/−;Pax9+/− mutants on a mixed C57BL/
6×BALB/c background exhibited hypoplastic incisors, which erupted
into the oral cavity but were chalky white and fragile, with hypo-
plastic cervical loops (data not shown).
Pax9+/−;Msx1+/− mutants form a small dental papilla and exhibit
severe growth defects of the lower incisor epithelium
To determine at which stage lower incisor primordia in Pax9+/−;
Msx1+/− mutants were morphologically affected, we carried out a
histological analysis between the early bud (E12.5) and the bell
(E15.5) stages (Figs. 4A–H). This analysis revealed that the dental
papilla of Pax9+/−;Msx1+/− mutant lower incisor primordia is
signiﬁcantly smaller at E13.5 (Fig. 4F). At E14.5, the mutant lower
incisors had progressed to the cap stage, but there was a pronounced
epithelial growth defect affecting both upper (lingual) and lower
(labial) incisor cervical loops, and a distinct enamel knot was not
recognizable (Fig. 4G). At E15.5, wild type incisor germs attain the bell
stage and a mesenchymal condensation is present next to each
cervical loop (arrows in Fig. 4D). In contrast, in Pax9+/−;Msx1+/−
mutants the paired condensations were absent and a single,
mesenchymal protrusion developed instead that extended from the
growth-retarded epithelium (Fig. 4H). In addition, whereas wild type
incisor growth is asymmetric, with the labial aspect longer than the
lingual (Fig. 4D), Msx1+/−;Pax9+/− mutant lower incisors showed a
high degree of symmetry, with a more nearly equivalent growth of
labial and lingual cervical loops (Fig. 4H).
The Pax9+/−;Msx1+/− lower incisor phenotype could be accounted
for by signiﬁcant reductions in the expression of Msx1, Pax9 or of both
genes. Since complete loss of Pax9 results in a severe reduction ofMsx1
expression during ﬁrst molar development (Peters et al., 1998; Ogawa
et al., 2006), we ﬁrst analyzed whether Pax9 expression requiresMsx1.
Immunostaining at the bud stage revealed that Pax9 expression is not
down-regulated in Msx1−/− mutants (Suppl. Fig. 1), demonstratingFig. 4. Growth retardation of Pax9+/−;Msx1+/−mutant incisors after the bud to cap stage tran
(E–H) lower incisor regions.Whereas themutant dental rudiment appears normal at E12.5 (E
the cervical loops of Pax9+/−;Msx1+/−mutant incisors are clearly growth-retarded (G). At E1
(arrows inD). In contrast, these condensations aremissing in Pax9+/−;Msx1+/−mutants and
ek, enamel knot; lcl, lower cervical loop; mc, Meckel's cartilage; tb, tooth bud; to, tongue; u
presented for each developmental stage.that Pax9 is expressed independently of Msx1 at the bud stage. Next,
we analyzed the expression of Pax9 and Msx1 in Pax9+/−;Msx1+/−
mutant lower incisors (Figs. 5A–L). At E12.5, Pax9 and Msx1 are co-
expressed mainly in the lingual half of the dental mesenchyme
(Figs. 5A and G). At the early cap stage, Pax9 expression is weak in the
direct vicinity of the forming enamel knot (Fig. 5C) and, subsequently,
is mainly associated with the mesenchyme adjacent to the upper and
lower cervical loops (Fig. 5E). In contrast, Msx1 transcripts are
abundant throughout the dental mesenchyme at E13.5 (Fig. 5I), and
high expression levels persist in the distal compartment of the dental
papilla (Fig. 5K). In Pax9+/−;Msx1+/− mutant incisors, the expression
levels and expression domains of Pax9 (Figs. 5B, D, and F) and Msx1
(Figs. 5H, J, and L) in lower incisor mesenchyme resembled those in
wild type incisors, though the domains were smaller after the growth
retardation became more pronounced in the mutant. In contrast, the
dental epithelial expression of Msx1 was qualitatively different
between Msx1+/−;Pax9+/− mutants and wild type littermates. In
E12.5Msx1+/−;Pax9+/−mutant lower incisors,Msx1was expressed in
both labial and lingual side dental epithelium (Fig. 5H), whereas Msx1
is asymmetrically expressed in wild type incisor epithelium (Fig. 5G).
At E13.5, when Msx1 was down-regulated in wild type incisor
epithelium (Fig. 5I), Msx1 transcripts persisted in Msx1+/−;Pax9+/−
mutant epithelium (Fig. 5J). Thus, while Msx1 expression is perturbed
in Msx1+/−;Pax9+/− mutants, the double heterozygous phenotype
cannot be explained simply on the basis of marked reductions in
mesenchymal Pax9 or Msx1 expression.
Pax9+/−;Msx1+/− mutants form a smaller lower incisor ﬁeld during
tooth initiation
The reduced size of the dental papilla ofMsx1+/−;Pax9+/−mutant
lower incisors at E13.5 indicates that Pax9 and Msx1 interact prior to
the bud stage. Since Pax9 and Msx1 are co-expressed at the time of
tooth initiation (Neubuser et al., 1997; Mackenzie et al., 1991), we
asked whether establishment of the lower incisor ﬁeld was affected.
Thiswas done by analysis of Bmp2, p21 and Shh expression (Figs. 6A–J),
which deﬁne the position and size of the dental primordia (Dassulesition. Panels showhistological staining of sagittal sections of normal (A–D) andmutant
), the size of the dental papilla (outlined by dotted line) is reduced at E13.5 (F). At E14.5,
5.5, mesenchymal condensations are normally established adjacent to each cervical loop
a uniformmesenchymal domain (outlined by dashed line) is formed (H). Abbreviations:
cl, upper cervical loop; vl, vestibular lamina; wt, wild type. Scale bars (all 100 µm) are
Fig. 5. Expression of Pax9 andMsx1 is not changed in Pax9+/−;Msx1+/− lower incisor mesenchyme. At E12.5, the expression domains of Pax9 (A) andMsx1 (G) mainly overlap in the
lingual half of the dental mesenchyme and these patterns are not changed in Pax9+/−;Msx1+/−mutants (B, H). Beginning at E13.5, Pax9 expression becomes down-regulated in the
direct vicinity of the enamel knot (arrow in C) and the domains withmaximal Pax9 andMsx1 expression levels begin to separate from each other (C, I), a pattern that is more obvious
at E14.5 (E, K). Although the expression domains are smaller in Pax9+/−;Msx1+/−mutant incisors, the overall patterns and expression levels are not changed (D, F, J, L). In the dental
epithelium, Msx1 is normally expressed asymmetrically at E12.5 (G) but is expressed in both labial and lingual sides in Pax9+/−;Msx1+/−mutants (H). In addition, Msx1 is down-
regulated in wild type incisor epithelium at E13.5 (I) but expression remains in Pax9+/−;Msx1+/−mutant epithelium (J). Abbreviations as in Fig. 4; scale bar indicates 100 µm and
applies to all panels.
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Linde et al., 2002). Collectively, the expression domains of these
markers are laterally truncated in Pax9+/−;Msx1+/− mutant lower
incisors (Figs. 6B, H, and J). Among these markers, Bmp2 expression
appeared to be most sensitive to Pax9;Msx1 double heterozygosity,
and was absent at E12.5 (Fig. 6D). Although Shh is expressed adjacent
to the prospective incisor epithelium itself at the early bud stage (inset
in Fig. 6I), the reduction of Shh expression also affected the lateral
domains (Fig. 6J). A Pax9;Msx1-dependent expression of Shh was
further demonstrated by its marked down-regulation in single
homozygous Pax9 and Msx1 mutants (Figs. 6K and L), and by a
complete absence of Shh incisor germ expression in Pax9−/−;Msx1−/−
mutants (Fig. 6M). Moreover, we identiﬁed a partial rescue of lateral
Shh expression in Pax9+/−;Msx1+/−;BMP4tg/tg triple mutants (Fig. 6N),
consistent with a previously demonstrated role of Bmp4 in inducing
Shh expression during early tooth development (Zhang et al., 2000).
Growth retardation of Pax9+/−;Msx1+/− lower incisors is associated
with a loss of mesenchymal Fgf3 and Fgf10 expression in the dental
papilla
To investigate potential molecular causes for the lower incisor
growth defects we analyzed the expression of Bmp4, Fgf3 and Fgf10
(Figs. 7A–X), which encode growth factors with important roles
during incisor morphogenesis and differentiation (Harada et al., 2002;
Wang et al., 2007). In addition, between E12.5 and E15.5, these genes
exhibit expression domains similar to those of Pax9 and Msx1 in the
dental mesenchyme. A reduced size of the Bmp4 expression domain
was detected in Pax9+/−;Msx1+/−mutant lower incisors at E12.5 and
E13.5, while an ectopic expression domain in the mesenchyme
separating the incisor and vestibular lamina was detected at E12.5
(Figs. 7B and D). At E14.5, Bmp4 is also normally expressed in theenamel knot (Fig. 7E) and this domain was either missing (Fig. 7F) or
severely reduced in Pax9+/−;Msx1+/− mutants. Expression of other
enamel knot markers, such as Shh, p21 and Lef1 was also reduced in
Pax9+/−;Msx1+/− mutants (Suppl. Fig. 2). In addition, the mesen-
chymal expression domain of Bmp4 in the mutants was signiﬁcantly
smaller compared to that of wild type lower incisors. At E15.5, two
domains of up-regulated Bmp4 expression that normally exist
adjacent to the growing tips of the dental epithelium (Fig. 7G) were
lacking in Pax9+/−;Msx1+/−mutants. Instead, Bmp4was expressed in
a domain that overlapped with the mesenchymal protrusion (Fig. 7H;
compare Fig. 4H). However, in contrast to earlier stages, at E15.5 Bmp4
appeared to be expressed in Pax9+/−;Msx1+/− mutant incisor
mesenchyme at levels similar to those in wild type incisors.
In contrast to the transient down-regulation observed for Bmp4,
the expression of Fgf3 was strongly affected in the mutants at all
stages and was down-regulated to undetectable levels from E14.5
onwards (Figs. 7J, L, N and P). Similar to Fgf3, mesenchymal Fgf10
expression was absent in Pax9+/−;Msx1+/− mutants at E14.5
(Fig. 7V). At E15.5, the strong mesenchymal expression of Fgf10 that
is normally present adjacent to the cervical loops (Fig. 7W) was
absent in Pax9+/−;Msx1+/− mutants (Fig. 7X). In contrast, there was
no signiﬁcant difference in the expression levels ofWnt5a, Runx2 and
Lef1 in Pax9+/−;Msx1+/−mutant incisor mesenchyme (Suppl. Fig. 2).
Moreover, expression levels of Fgf3 and Fgf10 during upper incisor and
molar development were indistinguishable from those in control
embryos (data not shown).
Previous studies have shown that the mitogenic activities of Fgf3
and Fgf10 stimulate epithelial growth during tooth morphogenesis
(Harada et al., 2002; Wang et al., 2007); we therefore hypothesized
that the severely reduced expression of Fgf3 and Fgf10 in Pax9+/−;
Msx1+/− lower incisors might affect cell proliferation. To test this
hypothesis, we carried out BrdU labeling assays (Figs. 8A–D, I). At
Fig. 6. Expression of dental epithelial markers is affected in Pax9;Msx1 double
heterozygous mutants. At E12.25 (A) and E13.5 (C), Bmp2 is expressed in wildtype
lower incisors and transcript levels are particularly high at the margins of the dental
epithelium (arrowheads). The lateral domains of Bmp2 expression are missing in the
double mutants at E12.25 (arrows in B) and the expression is absent at E12.5 (D).
Expression of p21 is weaker in double mutants (F) and the medio-lateral pattern is
disturbed at E12.5 (arrows in H). At E12.25, two Shh-positive domains (I) outline the
incisor region in control embryos. At this stage, Shh expression (arrowhead) is
restricted to the epithelium separating incisors and vestibular laminar (inset in I). In
Pax9+/−;Msx1+/−mutants, Shh transcripts are missing laterally (arrows in J), whereas
normal expression patterns of Shh are consistently observed in Pax9+/− or Msx1+/−
mutants (data not shown). Shh expression is drastically down-regulated in homozy-
gous Pax9−/− (K) or Msx1−/− (L) mutants and is absent in Pax9−/−;Msx1−/− mouse
mutants (M). A partial rescue of the Shh expression pattern is observed in Pax9+/−;
Msx1+/−;BMP4tg/tg mutants (N).
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pb0.001) in the mutant dental epithelium, and by 23±1%
(pb0.002) in the mutant dental mesenchyme (Figs. 8A, B, and I). At
14.5, the BrdU index was reduced by 25±2% (pb0.05) in the mutantdental epithelium and by 24±2% (pb0.01) in the mutant dental
mesenchyme (Figs. 8C, D, and I). In contrast, there was no obvious
difference in apoptosis between Pax9+/−;Msx1+/−mutants and wild
type incisors (Figs. 8E–H).
Loss of labial–lingual asymmetry in lower incisors of Pax9+/−;Msx1+/−
mutants
Incisor growth and differentiation in rodents is asymmetric, with the
labial cervical loop longer than the lingual and responsible for generating
functional ameloblasts (Fig. 9A). Pax9+/−;Msx1+/− mutant lower
incisors, though severely hypoplastic, appeared symmetric and exhibited
almost equivalent growth of both labial and lingual cervical loops
(Fig. 9B). This symmetric growthwasmaintained at least until E18.5 and,
in a C57BL/6;FVB;BALB/c genetic background was characterized by
columnar ameloblasts on both sides of the Pax9+/−;Msx1+/− mutant
incisors (Fig. 9B). The ectopic presence of functional ameloblasts at the
lingual aspect of Pax9+/−;Msx1+/−mutant incisorswas supportedby the
symmetric expression pattern of Ameloblastin (Fig. 9D). Normally, in
E16.5 wild type incisors, Follistatin transcripts are down-regulated in
differentiating ameloblasts on the labial side, while expression remains in
the undifferentiated inner dental epithelium on the lingual side (Fig. 9E;
Wang et al., 2004). In contrast, in Pax9+/−;Msx1+/− mutants, Follistatin
expression was down-regulated in both labial and lingual side dental
epithelium, with only a thin layer of dental epithelium near the cervical
loop regions retaining some follistatin transcripts (Fig. 9F). A partial loss of
lower incisor symmetrywas indicated as early as E14.5, when the lingual
epithelium of Pax9+/−;Msx1+/− mutants exhibited Shh expression
(Fig. 9H), whereas Shh is predominantly expressed in labial epithelium
inwildtype incisors (Fig. 9G).Moreover, the symmetrydefect in Pax9+/−;
Msx1+/− mutant incisors is preceded by a strong reduction of
mesenchymal expression of Notch1, while its expression was preserved
in the Pax9+/−;Msx1+/− mutant incisor epithelium (Figs. 9J, L, and N).
Interestingly, in contrast to the ectopic, ameloblast-speciﬁc gene
expression in the lingual incisor epithelium of Pax9+/−;Msx1+/−mutant
embryos, ameloblasts were completely missing in the rescued Pax9+/−;
Msx1+/−;BMP4tg/tg lower incisors (Fig. 3L), while the corresponding
control mice (Pax9+/+;Msx1+/+;BMP4tg/tg) had normal lower incisors
(data not shown).
Discussion
Previous work has shown that Pax9 andMsx1 are key regulators of
tooth development, as Pax9 or Msx1 nullizygosity in mice results in a
loss of the odontogenic potential of the dental mesenchyme and an
arrest of tooth formation at the bud stage (Satokata and Maas, 1994;
Peters et al., 1998). A drastic reduction of Pax9 gene dosage below that
of Pax9 heterozygosity is associated with missing teeth, with lower
incisors and third molars being the most susceptible tooth types (Kist
et al., 2005). Here we showed that the same tooth types are affected in
mice with concomitant heterozygosity of Pax9 and Msx1 and that the
lower incisor defects involve altered gene expression patterns shortly
after initiation, severe growth retardation during morphogenesis, and
a loss of asymmetry during differentiation. These results therefore not
only indicate a critical genetic interaction between Pax9 and Msx1 in
tooth development, but also identify previously unknown functions of
both genes at several different stages of odontogenesis.
Expression changes of epithelial markers are associated with early size
reduction of Pax9+/−;Msx1+/− mutant lower incisors
The dental lamina is speciﬁed at E11.5 of mouse embryogenesis
and expression of epithelial markers such as Bmp2, Shh and p21
subsequently identiﬁes the sites of developing ﬁrst molars and
incisors (Dassule and McMahon, 1998; Cobourne et al., 2001, Gritli-
Linde et al., 2002; Jernvall et al., 1998). In Pax9+/−;Msx1+/− mutant
Fig. 7. Fgf3 and Fgf10 expression is strongly affected by combined reduction of Pax9;Msx1 gene dosages. In situ hybridizations for Bmp4 (A–H), Fgf3 (I–P) and Fgf10 (Q–X) were
carried out on sagittal sections from E12.5 to E15.5. The mesenchymal expression of Bmp4 (outlined by dashed lines) is found in a smaller domain in the mutants at E12.5 and E13.5
(B, D). Expression in the future enamel knot region is evident in wildtype embryos (arrowheads in A, C, E) but not in the mutants (B, D, F). Ectopic expression of Bmp4 in the
mesenchyme separating tooth bud and vestibular lamina was detected in Pax9+/−;Msx1+/− mutants at E12.5 (arrow in B). At E15.5, strong Bmp4 expression is normally seen in
the mesenchyme adjacent to the cervical loops (G), whereas in the mutants these domains are missing (H). Note also the ectopic Bmp4 expression (arrow) outside the actual
incisor region. Expression of Fgf3 in the incisor mesenchyme is moderately down-regulated at E12.5 (J) and E13.5 (L) and was not detectable at subsequent stages (N, P).
Expression of Fgf10 was not affected in the mutants at E12.5 (R) and E13.5 (T), except for an ectopic domain separating tooth bud and vestibular lamina (arrow in R). Fgf10
expression was not detectable in Pax9+/−;Msx1+/−mutants at E14.5 (V). At E15.5, up-regulated Fgf10 expression associated with the cervical loops is detectable in normal incisors
(W) but was missing in Pax9+/−;Msx1+/−mutants (X). Both Fgf3 and Fgf10 are expressed at normal levels during upper incisor development (not shown). Scale bars (all 100 µm)
are presented for each developmental stage. Ek, enamel knot; lcl, lower cervical loop; tb, tooth bud; to, tongue; ucl, upper cervical loop; vl, vestibular lamina; wt, wild type.
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missing at E12.25 and E12.5, respectively. Thus, alterations in Pax9
and Msx1 gene dosage inﬂuence the size of tooth primordia during
initiation. Since Pax9 and Msx1 are co-expressed in dental mesen-
chyme, their interaction must therefore, directly or indirectly, affect
the expression and/or activity of secreted factors that control the
correct size and duration of a molecular response in the adjacent
dental epithelium.
Several lines of evidence suggest that this control, at least in part, is
mediated by the expression dependency of Bmp4 on Pax9 and Msx1.
First, the expression of Bmp4 shifts from the epithelium to the
mesenchyme at E11.5 and this expression is gradually lost in the
developing molars of Pax9 or Msx1 single homozygous mutants
(Vainio et al., 1993; Peters et al., 1998; Chen et al., 1996). Second,
Bmp4 is sufﬁcient to induce Shh expression in the epithelium ofMsx1-
deﬁcient tooth rudiments (Zhang et al., 2000; Zhao et al., 2000). Third,
a synergistic, Pax9/Msx1-mediated in vitro activation of transcription
from the basal Bmp4 promoter was identiﬁed in a non-dental cell line
(Ogawa et al., 2006). Finally, the lateral truncation of Shh expression
domains in Pax9+/−;Msx1+/− mutant lower incisors was partially
rescued by transgenic BMP4 expression as early as E12.25 (Fig. 2).
Whereas we identiﬁed slightly reduced expression domains of Bmp4
at E12.5 and E13.5 (Fig. 7), whole-mount in situ hybridization of Bmp4
in Pax9+/−;Msx1+/−mutant lower incisors failed to detect a laterally
truncated domain of mesenchymal Bmp4 expression prior to E12.25.
However, in addition to the limited sensitivity of this method to
quantify small expression changes, we cannot rule out that the Pax9/
Msx1 interaction in the dental mesenchyme may also affect other
aspects of the Bmp4 pathway. For example, a Pax9/Msx1 interaction
may be required to indirectly regulate Bmp4 protein stability or its
efﬁcient diffusion, both of which providing possible explanations for aspatially restricted response to Bmp4 signaling in the lower incisor
epithelium of Pax9+/−;Msx1+/− mutants.
Growth defects of Pax9+/−;Msx1+/− mutant lower incisors involve loss
of Fgf3 and Fgf10 expression in the dental papilla
Based onmorphological criteria, the ﬁrst recognizable defect of the
Pax9+/−;Msx1+/− lower incisor papilla is its reduced size at E13.5, a
defect that is preceded by a smaller expression domain of Bmp4 and
by an absence of Fgf3 expression in the dental mesenchyme at E12.5.
Whereas in the mutants Fgf3 was weakly expressed at E13.5, Fgf3
expression was not detectable from E14.5 onwards and Fgf10
expression was strongly reduced at all stages analyzed. Fgf3 and
Fgf10 have redundant functions during tooth development and not
only regulate the proliferation of the mesenchymal cells of the dental
papilla, but also act as mitogens in epithelial stem cells and transient
amplifying (TA) cells in the lower incisor cervical loop (Harada et al.,
2002; Wang et al., 2007). Consistent with these functions, lower
incisor development is strongly affected in Fgf3−/−;Fgf10+/− com-
pound mutant mice, whereas molars are less affected (Wang et al.,
2007). In addition, recent work has identiﬁed important roles of FGF3
and FGF10 in the regulation of tooth size in humans (Tekin et al., 2007;
Alsmadi et al., 2009; Milunsky et al., 2006; Shams et al., 2007). We
thus conclude that the down-regulation of Fgf3 and Fgf10 expression
in Pax9+/−;Msx1+/− mutants is likely to be a major cause of the
reduced cell proliferation and lower incisor growth defects.
Loss of lower incisor asymmetry
The speciﬁc growth rates and differentiation pathways of labial and
lingual dental epithelia are key features of the continuously growing
Fig. 8. Cell proliferation is reduced in Pax9+/−;Msx1+/− mutant lower incisors. (A–D) Detection of BrdU-positive cells in wild type and Pax9+/−;Msx1+/− mutant lower incisors.
Note the absence of BrdU incorporation in the future enamel knot cells of the wild type incisor (arrow A), whereas a BrdU-negative area is less evident in the mutant (B). (E–H)
TUNEL staining does not show signiﬁcant differences in apoptosis in wild type and Pax9+/−;Msx1+/− mutant incisors. (I) Reduction of BrdU index in Pax9+/−;Msx1+/− mutant
lower incisors in the dental epithelium (DE) and dental mesenchyme (DM) compared with wild type incisors. Scale bars: 100 µm.
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enamel-secreting ameloblasts, the lingual cervical loop is small and
does not produce functional ameloblasts. This asymmetry is controlled
by a complex regulatory network involving the Follistatin-mediated
inhibition of ameloblast differentiation at the lingual aspect (Wang et
al., 2004) and by a Fgf3/Fgf10-mediated growth stimulation predom-
inantly at the labial aspect (Wang et al., 2007). Although lower incisors
are strongly growth-retarded inMsx1+/−;Pax9+/−mutants, the absent
expression of Fgf3 and the weak but uniform expression of Fgf10 at
E15.5 is consistent with similarly sized labial and lingual cervical loops.
Moreover, the loss of asymmetric differentiation indicated by ectopic
Ameloblastin expression in lingual dental epithelium is associated with
an abnormal down-regulation of Follistatin expression in both labial
and lingual dental epithelium in Msx1+/−;Pax9+/− mutants. Interest-
ingly, in contrast to the ectopic formation of ameloblasts in the
embryo, functional ameloblasts were entirely missing in the hypo-
plastic incisors of adult Msx1+/−;Pax9+/− mutants kept on a mixed
C57BL/6×BALB/c background (data not shown), as well as in the
rescued incisors of Pax9+/−;Msx1+/−;BMP4tg/tg mice (Fig. 4L). A likely
explanation for the stage-speciﬁc difference of the phenotype may be
that Pax9 and Msx1 continue to interact in the incisor mesenchyme of
adult mice to regulate transcription Fgf3 and Fgf10. Thus, in certain
genetic backgrounds the expression levels of Fgf3 and Fgf10 are
apparently sufﬁcient for early incisor growth, however, the levels
could be insufﬁcient to maintain an epithelial stem cell pool over a long
period. Experimental strategies that inactivate Pax9 and Msx1 in adultmice will be required to directly test the involvement of Pax9 andMsx1
in the maintenance of dental stem cell compartments.
The ﬁrst molecular events that establish lower incisor asymmetry
are unknown, but may involve cell fate decisions at the bud stage.
Notably, at E12.5, Msx1 is expressed in labial side dental epithelium,
whereasMsx1+/−;Pax9+/−mutant lower incisors lose this asymmet-
ric expression, withMsx1 expression in both labial and lingual dental
epithelium. At E13.5, when Msx1 becomes down-regulated in wild
type incisor epithelium,Msx1 transcripts persist inMsx1+/−;Pax9+/−
mutant incisor epithelium. Although this may simply reﬂect the
growth retardation ofMsx1+/−;Pax9+/−mutant lower incisors, it will
be interesting to determine whether the asymmetric epithelial
expression of Msx1 contributes to the asymmetric growth and dif-
ferentiation of mouse incisors.
In addition to abnormalMsx1 expression in incisor epithelium, we
found Notch1 to be markedly down-regulated in the dental mesen-
chyme of Msx1+/−;Pax9+/− mutant incisors at E12.5 and E13.5.
Notch1 is expressed in the dental epithelium of developing molars at
the dental lamina and bud stages, and in both dental epithelium and
mesenchyme at the cap stage (Mitsiadis et al., 1995). In the
developing mouse incisors, Notch signaling has been implicated in
the regulation of epithelial cell fate in the cervical loops (Tummers
et al., 2007). Notch1 seems to be expressed in the incisor mesenchyme
earlier than in molar teeth. Interestingly, FGF10 has been shown to
stimulate expression of lunatic fringe, a regulator of Notch signaling,
and it has been proposed that FGF signaling is linked to cell fate
447M. Nakatomi et al. / Developmental Biology 340 (2010) 438–449decisions in incisor stem cells (Harada et al., 1999; Mustonen et al.,
2002). Since Notch1 knockout mice die early during mid-gestation
(Swiatek et al., 1994), conditional deletion of Notch1 in the dental
mesenchyme will be required to investigate its role in the establish-
ment of epithelial asymmetry in rodent incisors.
Genetic interactions in oligodontia, selective tooth agenesis and orofacial
clefting
The causes for the majority of congenital, sporadic forms of missing
teeth in humans are unknown, and gene–gene interactions mayunderlie a signiﬁcant number of these cases. Based on the large number
of studies showing that mutations in PAX9 or MSX1 cause non-
syndromic oligodontia, both genes are promising candidates for an
involvement in causative gene–gene interactions. A previous study
found that concomitant polymorphisms in MSX1 and PAX9 were over-
represented in a small groupof humanhypodontia patients (Vieira et al.,
2004). Our ﬁndings provide direct evidence for a genetic interaction
between heterozygous Pax9 and Msx1 loss-of-function mutations that
result in oligodontia in mice. The missing lower incisors and
background-dependent absence of third molars in Msx1+/−;Pax9+/−
mutant mice mimic sporadic hypodontia. Comprehensive mutation
analyses including regulatory promoter and enhancer regions of PAX9
and MSX1 may help to uncover the genetic basis for some types of
sporadic hypodontia in humans,
Msx1 and Pax9 are expressed similarly in both upper and lower
incisors, as well as in molars, but our data shows that in Msx1+/−;
Pax9+/− mutants the growth retardation and disruption of Pax9/
Msx1-dependent developmental pathways affects only some tooth
types. In particular, while Pax9 and Msx1 expression are maintained
at reduced levels inMsx1+/−;Pax9+/− lower incisors, Fgf3 expression
is completely lost after the bud stage. This ﬁnding suggests that Pax9
and Msx1 are involved in antagonizing a genetic pathway that
inhibits Fgf3 expression. While this pathway remains to be identiﬁed,
it appears to be particularly potent in the dental ﬁeld of lower incisors,
thus providing a potential explanation for the increased dosage
sensitivity of lower incisor development. Consistent with this view,
different responses to molecular changes have been reported for
various tooth types. For example, Fgfr2 loss-of-functionmutations lead
to defective maxillary incisors, whereas lower incisors and molars are
unaffected (Lin et al., 2009). It has been suggested that different tissue
origins may underlie these different genetic sensitivities. Maxillary
incisors arise from the fronto-nasal process and neural crest-derived
ectomesenchymal cells that migrate from caudal midbrain and rostral
hindbrain,whilemandibular incisors arise from theﬁrst branchial arch
and neural crest-derived ectomesenchymal cells thatmigrate from the
hindbrain (Cobourne and Mitsiadis, 2006). Speciﬁc patterns of
homeobox-containing genes indicate that different identities of
these cell populations are maintained during odontogenesis
(Cobourne and Sharpe, 2003), and it seems plausible that Pax9 and
Msx1 interact differentlywith distinct tooth-speciﬁc genetic programs.
Lastly, cleft lip with or without cleft palate (CL/P) and cleft palate
only (CPO) are among the most frequent developmental birth defects,
with prevalences as high as 1/500 in some populations; studies
suggest that more than 50% of cases are not associated with a
syndrome (Murray, 2002). A combination of genetic interactions and
environmental factors has been suggested to underlie most sporadic
cases, but the identiﬁcation of genes that play a major role in this
multifactorial process is difﬁcult (Jugessur and Murray, 2005; Vieira
et al., 2005). Interestingly, CL/P and CPO are often associated withFig. 9. Loss of lower incisor asymmetry in Pax9+/−;Msx1+/−mutants. (A, B) Hematoxylin
and eosin stained sagittal sections. (A) Inwild type incisors, the labial (lab) cervical loop is
larger than the lingual (lin) cervical loop andproduces functional ameloblasts (arrow). The
dental papilla (dp) consists of loose mesenchyme and odontoblasts are seen on the labial
and lingual aspect (arrowheads). (B) In Pax9+/−;Msx1+/− mutants, the cervical loops
have a similar size and ameloblasts are abnormally formed at both labial and lingual sides
(arrows). In contrast, odontoblasts are missing and bone-like tissue forms instead of a
dental papilla. Loss of asymmetry in Pax9+/−;Msx1+/−mutants is also evident by lingual
expression of Ameloblastin (arrow in D). (E) Follistatin is normally maintained at the
lingual side (arrowheads) and isdown-regulated at the labial side (arrow). (F) InPax9+/−;
Msx1+/−mutants, down-regulationof Follistatin is seen inbothaspects (arrows).Asterisks
(D, F) indicate a large blood vessel that frequently forms in the mutants at later stages
(compare also Fig. 4H). Loss of asymmetry is also evident by up-regulated expression of
Shh in the lingual epithelium of Pax9+/−;Msx1+/−mutants (H). (I, K)Notch1 is expressed
in the dental mesenchyme at E12.5 at E13.5 in wild type embryos and the expression is
markedly down-regulated inPax9+/−;Msx1+/−mutants at both stages (J, L). At E14.5, two
stripes of Notch1 expression dividing lingual and labial halves of the lower incisor
mesenchyme are seen in wild type (M) but not in Pax9+/−;Msx1+/− mutants (N).
Abbreviations: mc, Meckel’s cartilage. Scale bars: 100 µm.
448 M. Nakatomi et al. / Developmental Biology 340 (2010) 438–449missing teeth, and recent analyses indicate that the incidence of
missing teeth is signiﬁcantly higher even outside the cleft region and
in themandibular jaw (Shapira et al., 2000; Slayton et al., 2003). These
data suggest that upper lip, secondary palate and teeth share some
genetic pathways during their development. In humans, CL/P has
been identiﬁed in oligodontia patients with heterozygous MSX1
mutations (summarized in Vieira, 2008). In addition, speciﬁc poly-
morphisms in PAX9 or MSX1 have recently been associated with cleft
lip in humans (Ichikawa et al., 2006; Modesto et al., 2006). CL/P is a
relatively rare craniofacial abnormality in mice, but our data show
that this phenotype manifests in Pax9−/−;Msx1−/− mouse mutants
on a mixed C57BL/6J;CBA/J;CD1 genetic background. However, the
incomplete penetrance and variable expressivity (unilateral or
bilateral cleft lip) indicate that additional genetic modiﬁers contribute
to cleft lip formation in this digenic mouse model. Pax9/Msx1-
deﬁcient mouse models may facilitate the identiﬁcation of critical
genetic modiﬁers of CL/P and help to elucidate the role of genetic
interactions in non-syndromic craniofacial abnormalities.
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